RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
REPLIGEN CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$176.43+1.01 (+0.58%)
Close on Oct 19, 2026
- Market cap
- $9.99B
- P/E (TTM)
- 205.2
- Dividend yield
- –
Repligen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Repligen | Industry median |
|---|---|---|
| Market Cap | $9.96B | $164.85M |
| Enterprise Value | $9.15B | $87.06M |
| PS Ratio | 12.68 | 3.60 |
| PB Ratio | 4.71 | 2.03 |
| P/TBV Ratio | 15.31 | 2.31 |
| P/FCF Ratio | 88.93 | 17.44 |
| P/OCF Ratio | 73.83 | 13.32 |
Enterprise value
| Measure | Repligen | Industry median |
|---|---|---|
| EV / Sales | 11.65 | 2.43 |
| EV / EBITDA | 63.79 | 14.69 |
| EV / EBIT | 141.57 | 18.47 |
| EV / FCF | 81.69 | 20.97 |
Income (trailing twelve months)
| Measure | Repligen | Industry median |
|---|---|---|
| Revenue | $785.10M | $57.94M |
| Gross Profit | $422.67M | $90.47M |
| Operating Income | $64.61M | -$21.44M |
| Pretax Income | $52.15M | -$14.45M |
| Net Income | $41.54M | -$22.46M |
| EBITDA | $143.39M | -$16.91M |
Margins
| Measure | Repligen | Industry median |
|---|---|---|
| Gross Margin | 53.8% | 52.3% |
| Operating Margin | 8.23% | -44.5% |
| Pretax Margin | 6.64% | -13.0% |
| Profit Margin | 5.29% | -39.2% |
| EBITDA Margin | 18.3% | -31.3% |
| FCF Margin | 14.3% | -8.85% |
Returns
| Measure | Repligen | Industry median |
|---|---|---|
| Return on Equity (ROE) | 1.99% | -53.1% |
| Return on Assets (ROA) | 1.42% | -41.0% |
| Return on Invested Capital (ROIC) | 3.88% | -32.0% |
| Return on Capital Employed (ROCE) | 2.29% | -37.8% |
Growth
| Measure | Repligen | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 16.5% | 6.01% |
| FCF Growth (YoY) | 2.79% | 2.34% |
| Revenue Growth (3Y CAGR) | -2.70% | 2.25% |
| Revenue Growth (5Y CAGR) | 15.0% | 6.42% |
| EPS Growth (3Y CAGR) | -35.7% | -0.17% |
| EPS Growth (5Y CAGR) | -4.98% | 3.77% |
Balance sheet
| Measure | Repligen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $810.45M | $62.42M |
| Net Cash (Debt) | $810.45M | $15.68M |
| Net Cash Per Share | $14.36 | $0.66 |
| Equity (Book Value) | $2.11B | $48.79M |
| Book Value Per Share | $37.42 | $1.36 |
| Tangible Book Value | $650.23M | $23.06M |
| Working Capital | $1.07B | $75.77M |
Financial position
| Measure | Repligen | Industry median |
|---|---|---|
| Current Ratio | 9.05 | 3.30 |
| Quick Ratio | 7.30 | 2.39 |
| Interest Coverage | 2.92 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Repligen | Industry median |
|---|---|---|
| Operating Cash Flow | $134.86M | -$12.35M |
| Capital Expenditures | -$22.90M | -$1.06M |
| Free Cash Flow | $111.97M | -$20.28M |
| FCF Per Share | $1.98 | -$0.42 |
Efficiency
| Measure | Repligen | Industry median |
|---|---|---|
| Asset Turnover | 0.27 | 0.38 |
| Inventory Turnover | 2.12 | 2.67 |
| Revenue Per Employee | $392.55K | $398.96K |
| Profits Per Employee | $20.77K | -$703.34K |
| Employee Count | 2,000 | 74 |
Dividends and yields
| Measure | Repligen | Industry median |
|---|---|---|
| Earnings Yield | 0.42% | -22.7% |
| FCF Yield | 1.12% | -9.07% |
Shares
| Measure | Repligen | Industry median |
|---|---|---|
| Shares Outstanding | 56,435,600 | 58,179,650 |
| Shares Change (YoY) | 0.21% | 11.1% |
| Shares Change (QoQ) | 0.05% | 0.54% |
| Float | 56,055,900 | 49,173,100 |
| Shares Held by Insiders | 0.67% | 11.6% |
| Shares Held by Institutions | 117.2% | 59.4% |
Taxes
| Measure | Repligen | Industry median |
|---|---|---|
| Income Tax | $10.61M | $91.50K |
| Effective Tax Rate | 20.3% | 20.6% |
Scores
| Measure | Repligen | Industry median |
|---|---|---|
| Altman Z-Score | 8.12 | -0.24 |
| Piotroski F-Score | 7 | 4 |
| Beneish M-Score | -2.53 | -2.62 |
Calculated by StockData from Repligen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.